From predictions to prescriptions: A data-driven response to COVID-19

Dimitris Bertsimas,Leonard Boussioux,Ryan Cory-Wright,Arthur Delarue,Vassilis Digalakis,Alexandre Jacquillat,Driss Lahlou Kitane,Galit Lukin,Michael Li,Luca Mingardi,Omid Nohadani,Agni Orfanoudaki,Theodore Papalexopoulos,Ivan Paskov,Jean Pauphilet,Omar Skali Lami,Bartolomeo Stellato,Hamza Tazi Bouardi,Kimberly Villalobos Carballo,Holly Wiberg,Cynthia Zeng

DOI: https://doi.org/10.1007/s10729-020-09542-0

2021-02-15

Health Care Management Science

Abstract:The COVID-19 pandemic has created unprecedented challenges worldwide. Strained healthcare providers make difficult decisions on patient triage, treatment and care management on a daily basis. Policy makers have imposed social distancing measures to slow the disease, at a steep economic price. We design analytical tools to support these decisions and combat the pandemic. Specifically, we propose a comprehensive data-driven approach to understand the clinical characteristics of COVID-19, predict its mortality, forecast its evolution, and ultimately alleviate its impact. By leveraging cohort-level clinical data, patient-level hospital data, and census-level epidemiological data, we develop an integrated four-step approach, combining descriptive, predictive and prescriptive analytics. First, we aggregate hundreds of clinical studies into the most comprehensive database on COVID-19 to paint a new macroscopic picture of the disease. Second, we build personalized calculators to predict the risk of infection and mortality as a function of demographics, symptoms, comorbidities, and lab values. Third, we develop a novel epidemiological model to project the pandemic's spread and inform social distancing policies. Fourth, we propose an optimization model to re-allocate ventilators and alleviate shortages. Our results have been used at the clinical level by several hospitals to triage patients, guide care management, plan ICU capacity, and re-distribute ventilators. At the policy level, they are currently supporting safe back-to-work policies at a major institution and vaccine trial location planning at Janssen Pharmaceuticals, and have been integrated into the US Center for Disease Control's pandemic forecast.

health policy & services